BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2020 2:43:56 PM | Browse: 1423 | Download: 3148
 |
Received |
|
2020-01-04 23:29 |
|
Peer-Review Started |
|
2020-01-04 23:29 |
|
First Decision by Editorial Office Director |
|
2020-02-24 22:44 |
|
Return for Revision |
|
2020-02-24 22:44 |
|
Revised |
|
2020-03-27 16:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-05-27 06:09 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-05-28 03:04 |
|
Articles in Press |
|
2020-05-28 03:04 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-03 02:15 |
|
Publish the Manuscript Online |
|
2020-06-06 14:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
|
| Manuscript Source |
Invited Conference Manuscripts |
| All Author List |
Shereen A Saleh, Mohamed M Salama, Marwan M Alhusseini and Ghada A Mohamed |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ghada A Mohamed, MD, Lecturer, Gastroenterology and Hepatology Unit, Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Khalifa El-Maamon St., Abbassia, Cairo 11341, Egypt. ghadaabdelrahman@med.asu.edu.eg |
| Key Words |
Hepatitis C virus; Liver fibrosis; Human Mac-2 binding protein; Antiviral agents; Sustained virologic response; Elastography |
| Core Tip |
For 12 wk, 80 chronic hepatitis C patients received a sofosbuvir/daclatasvir/± ribavirin treatment. All patients achieved sustained virologic response (SVR12). Serum Mac-2 binding protein glycosylation isomer (M2BPGi) levels, liver stiffness measurements, fibrosis-4 (FIB-4) and PAPAS index decreased significantly at SVR12. At baseline, M2BPGi was the best marker to distinguish patients with grade F4 fibrosis, patients with grade F2 from grade F0-1 fibrosis, patients with grade F3-4 from grade F0-2 fibrosis, and patients with grade F2-4 from grade F0-1 fibrosis. At SVR12, M2BPGi had the greatest AUCs for differentiating patients with grade F4 fibrosis, patients with grade F3 from grade F0-2 fibrosis, patients with grade F3-4 from grade F0-2 fibrosis, and patients with grade F2-4 from grade F0-1 fibrosis. |
| Publish Date |
2020-06-06 14:43 |
| Citation |
Saleh SA, Salama MM, Alhusseini MM, Mohamed GA. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals. World J Gastroenterol 2020; 26(21): 2864-2876 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i21/2864.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i21.2864 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
